Compound Profiles
BPC-157 Peptide: A Comprehensive Review of Published Preclinical Research
Healthy Aminos Research Team · · 7 min read
Molecular Profile
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide with the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its molecular weight is 1419.53 Da (CAS: 137525-51-0). The compound was first characterized in the early 1990s as a fragment of a larger protein isolated from human gastric juice.
Unlike many peptides that degrade rapidly in acidic environments, BPC-157 has been observed to maintain stability in human gastric juice — an unusual property attributed to its proline-rich sequence.
Published Preclinical Research
### Tendon and Fibroblast Studies
In a 2011 in vitro and ex vivo study, [Chang et al.](https://pubmed.ncbi.nlm.nih.gov/21030672/) examined BPC-157's effects on tendon fibroblast cultures derived from rat Achilles tendons. The researchers reported dose-dependent increases in fibroblast migration and observed activation of the FAK-paxillin signaling pathway — a cascade involved in cell adhesion and motility. The study used concentrations ranging from 1 to 100 nM and found statistically significant increases in cell migration at 10 nM and above.
### Multi-Model Wound Healing Review
[Seiwerth et al. (2021)](https://pubmed.ncbi.nlm.nih.gov/34267654/) published a comprehensive review examining BPC-157 across multiple rodent wound healing models. The review covered studies on skin wounds, gastric lesions, and vascular models. The authors noted consistent findings across models but emphasized that the majority of published data comes from a single research group and that large-scale independent replication studies remain limited.
### Early Multi-Tissue Studies
In one of the foundational publications, [Seiwerth & Sikiric (1997)](https://pubmed.ncbi.nlm.nih.gov/9403790/) examined BPC-157 in rat models across skin wounds, colon anastomoses, and sponge angiogenesis assays. The study reported accelerated wound closure measurements and increased vascular density in the sponge model compared to vehicle controls.
Current Research Status
BPC-157 has over 100 published papers, predominantly from preclinical (animal model) research. As of 2026, large-scale human clinical trials have not been published. The compound remains classified as a research chemical and is not FDA-approved for any diagnostic or therapeutic application.
Quality Considerations
Research-grade [BPC-157](/peptides/healing/bpc-157) should have ≥98% purity verified by HPLC, with mass spectrometry confirming the expected molecular weight of 1419.53 Da. Storage at -20°C in lyophilized form maintains stability for 24+ months.
*All Healthy Aminos products are for research use only. Not for human or animal consumption. Not FDA approved.*
Research Use Only
FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.